Deepak Srivastava's guest appearances

Deepak Srivastava

The Stem Cell Podcast

Carry the One Radio: The Science Podcast

iBiology Videos Without Subtitles

iBiology Videos

Gridlock Break

Benoit Bruneau

Juergen Knoblich

Kristen Brennand

Arun Sharma

Scott Noggle

Peter Lengyel

Charles Murry

Ubaka Ogbogu

Tilo Kunath

Chris Armstrong

Mark Tomishima

Lior Gepstein

Heather Rooke

Steven Goldman

Jun Wu

OwlTail

Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease and director of the Roddenberry Stem Cell Center. At UC San Francisco (UCSF), Srivastava is a professor in the departments of pediatrics and biochemistry and biophysics. Today, he discusses novel approaches to COVID-19 diagnostic testing, treatments, and prevention. Dr. Srivastava dives right into the three key components of the COVID-19 pandemic that will affect how we move forward. He maintains that chief among those components - testing, treatment, and prevention via vaccine - is the improvement needed to diagnostic testing. By moving from the current method of lab testing, which is expensive and tests by amplifying viral genomes, to a test done in real time, we can begin reopening businesses and resuming a sense of normalcy. One possibility he suggests is the work being done by a virologist at the Gladstone Institute using CRISPR technology and enabling a smartphone camera to operate as a microscope, eliminating the need to amplify genomes and send every test to a lab for results. Go to NoLabels.org to learn more about how we are bringing together a bipartisan group of public and private leaders working to stop the virus, save lives and get Americans back to work.

Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease and director of the Roddenberry Stem Cell Center. At UC San Francisco (UCSF), Srivastava is a professor in the departments of pediatrics and biochemistry and biophysics. Today, he discusses novel approaches to COVID-19 diagnostic testing, treatments, and prevention. <br><br>Dr. Srivastava dives right into the three key components of the COVID-19 pandemic that will affect how we move forward. He maintains that chief among those components - testing, treatment, and prevention via vaccine - is the improvement needed to diagnostic testing. By moving from the current method of lab testing, which is expensive and tests by amplifying viral genomes, to a test done in real time, we can begin reopening businesses and resuming a sense of normalcy. One possibility he suggests is the work being done by a virologist at the Gladstone Institute using CRISPR technology and enabling a smartphone camera to operate as a microscope, eliminating the need to amplify genomes and send every test to a lab for results. <br><br>Go to <a href="http://NoLabels.org" rel="nofollow" target="_blank">NoLabels.org</a> to learn more about how we are bringing together a bipartisan group of public and private leaders working to stop the virus, save lives and get Americans back to work.

Dr. Deepak Srivastava and the Science of Infection, Testing, and Treatment

Dr. Deepak Srivastava is the President of the Gladstone Institutes and the International Society for Stem Cell Research, and the co-founder of Tenaya Therapeutics. His lab investigates the gene networks that guide cardiogenesis by developing models of heart disease using patient-derived iPSCs and CRISPR technology.

Ep. 165: “Tackling Heart Disease” Featuring Dr. Deepak Srivastava

A cardiologist studies stem cells and heart development

Regenerating the heart: Dr. Deepak Srivastava, Gladstone Institute of Cardiovascular Disease